Reliance GeneMedix

GeneMedix is a biopharmaceutical company specializing in the development and manufacture of biosimilar versions of high-value protein-based drugs. Originally established in the UK, the company focuses on complex biologics including erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), and various monoclonal antibodies. Following its acquisition by Reliance Life Sciences, GeneMedix serves as a key European hub for the group's biosimilar pipeline, leveraging its manufacturing facility in Ireland. The company's business model centers on providing affordable access to life-saving biological therapies across global markets.